Stock Track | Liquidia Technologies Soars 7.05% Intraday on Upbeat Q1 Results and Analyst Upgrades

Stock Track05-13

Liquidia Technologies Inc (LQDA) saw its stock price soar 7.05% during intraday trading on Tuesday, following the company's release of better-than-expected first-quarter financial results.

The biopharmaceutical company reported quarterly earnings of 52 cents per share, beating analyst estimates of 41 cents per share, with sales of $132.865 million also exceeding expectations of $116.675 million. CEO Dr. Roger Jeffs highlighted sustained uptake of YUTREPIA in pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

Following the strong earnings report, multiple analysts raised their price targets on Liquidia, including Wells Fargo increasing from $51 to $62, H.C. Wainwright raising from $55 to $67, and Raymond James boosting from $59 to $68. These positive analyst actions contributed to the stock's significant intraday gain.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment